Open AccessCrossover randomized study comparing the efficacy and tolerability of preservative-free Tafluprost 0.0015% to Latanoprost 0.005% in patients with primary open-angle glaucoma
Author(s) -
Sherein M Hagras,
Omar K H Al-Duwailah,
Mossief,
Ameera G Abdelhameed
Publication year - 2021
Publication title -
indian journal of ophthalmology/indian journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 51
eISSN - 1998-3689
pISSN - 0301-4738
DOI - 10.4103/ijo.ijo_165_21
Subject(s) - medicine , tolerability , latanoprost , intraocular pressure , glaucoma , ophthalmology , crossover study , open angle glaucoma , exacerbation , randomized controlled trial , prospective cohort study , surgery , adverse effect , placebo , alternative medicine , pathology
To compare the efficacy and the tolerability of preservative-free Tafluprost 0.0015% (TP) vs Latanoprost 0.005% (LP) in patients with primary open-angle glaucoma (POAG).